PTSD which has been identified in up to 23% of post-9-11 veterans often results in a chronic pernicious course. Thus effective treatments are imperative. The Institute of Medicine IOM concluded that the only intervention for PTSD with sufficient evidence to conclude efficacy is exposure therapy. This Phase III trial compares the efficacy of exposure therapy for combat-related PTSD delivered in two different formats- via virtual reality exposure therapy VRE or prolonged exposure therapy PE- combined with D-Cycloserine DCS a cognitive enhancer shown to facilitate the extinction of fear. Enhanced exposure therapy for combat-related Posttraumatic Stress Disorder PTSD: Study protocol for a randomized controlled trial.